This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Skogsberg A, Tobin G, Krober A, Kienle D, Thunberg U, Aleskog A et al. The G(−248)A polymorphism in the promoter region of the bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukaemia. Leukemia 2006; 20: 77–81.
Nuckel H, Frey UH, Sellman L, Bau M, Durig J, Durhsen U et al. Bax gene G(−248)A promoter polymorphism and chronic lymphocytic leukaemia: lack of association with incidence, disease stage and progression-free survival. Leukemia 2006; 20: 724.
Starczynski J, Pepper C, Pratt G, Hooper L, Thomas A, Milligan D et al. Common polymorphism G(−248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukemia once treatment is initiated. J Clin Oncol 2005; 23: 1514–1521.
Saxena A, Moshynska O, Sankaran K, Viswanathan S, Sheridan DP . Association of a novel single nucleotide polymorphism, G(−248)A, in the 5′-UTR of BAX gene chronic lymphocytic with disease progression and treatment resistance. Cancer Lett 2002; 187: 199–205.
Pepper C, Hoy T, Thomas A, Bentley DP . Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2 expressing subclones. Br J Haematol 1999; 104: 581–588.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fegan, C., Starczynski, J., Pratt, G. et al. The role of the bax gene polymorphism G(−248)A in chronic lymphocytic leukemia. Leukemia 20, 1460–1461 (2006). https://doi.org/10.1038/sj.leu.2404280
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404280